Table 2 Itemized cost results
Type of cost | Cost parameter | Cost in US$ 2012, mean (95Â % CI) |
|---|---|---|
Intervention cost | Average SP price per administrationa | 0.2 (0.16–0.25) |
Average AL price per administrationa | 2.39 (1.71–3.06) | |
Average RDT price per administrationa | 0.81 (0.58–0.90) | |
HCW time cost per dose of IPTp-SP | 0.59 (0.33–0.91) | |
HCW time cost per administration of ISTp-AL if screened negative | 0.64 (0.36–1.00) | |
HCW time cost per administration of ISTp-AL if screened positive | 0.84 (0.47–1.31) | |
Total cost per administration of IPTp-SP (HCW time and commodity cost) | 0.79 (0.53–1.12) | |
Total cost per administration of ISTp-AL if screened negative (HCW time and commodity cost) | 1.45 (1.12–1.85) | |
Total cost per administration of ISTp-AL if screened positive (HCW time and commodity cost) | 4.06 (3.29–4.97) | |
Health provider costs excluding medical supplies | Cost per OP visit | 11.78 (9.18–14.68) |
Cost per IP day adult | 35.27 (19.99–55.07) | |
Cost per paediatric IP day (nursery) | 63.51 (36.3–99.27) | |
Health provider costs of consequences | Total average short term cost per LBW baby | 40.93 (19.52–71.19) |
Total average cost per moderate/severe anaemia case | 10.15 (6.76–15.17) | |
Total average cost per clinical malaria case | 13.71 (6.12–24.65) |